Proov Overview
- Founded
- 2016
- Status
- Private
- Employees
- 14
- Latest Deal Type
- Series A
- Latest Deal Amount
- $9.7M
- Investors
- 12
Proov General Information
Description
Developer of urine progesterone test strips designed to track ovulation and diagnose hormonal imbalances at home. The company's strips offer a rapid five-minute test that measures hormones in the first half of the menstrual cycle and identifies hormonal problems that cause infertility and miscarriage, thereby enabling women to track hormones and treat issues with less cost than fertility centers and IVF treatments.
Contact Information
Website
www.proovtest.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Specialty Retail
Primary Office
- 1360A 30th Street PMB 143
- Boulder, CO 80301
- United States
+1 (720) 000-0000
Proov Timeline
Proov Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series A) | 07-Dec-2021 | $9.7M | 0000 | Completed | Generating Revenue | |
| 7. Later Stage VC | 01-Jul-2021 | 00.000 | 00.00 | Completed | Generating Revenue | |
| 6. Accelerator/Incubator | 01-Apr-2021 | 00.000 | Completed | Generating Revenue | ||
| 5. Early Stage VC | 09-Sep-2020 | 00.000 | 00.000 | 000.00 | Completed | Generating Revenue |
| 4. Grant | 17-Dec-2019 | 0000 | 00000 | Completed | Generating Revenue | |
| 3. Seed Round | 18-Oct-2018 | 00000 | 00000 | 00.00 | Completed | Generating Revenue |
| 2. Grant | 10-Jul-2018 | $250K | Completed | Generating Revenue | ||
| 1. Product Crowdfunding | 13-May-2016 | $44K | Completed | Generating Revenue |
Proov Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series Growth | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.00 | |
| Seed | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
Proov Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of urine progesterone test strips designed to track ovulation and diagnose hormonal imbalances at home. The co
Other Devices and Supplies
Boulder, CO
14
As of 2021
0000
00000000000
0000
0000
reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaeca
00000000000 00000000 (000)
New York, NY
00
As of 0000
00.00
0.00
0000-00-00
000000000
00.00
00000000
elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, q
00000 0000000000 00000000
Dublin, Ireland
000
As of 0000
00000
00
0000-00-00
00000000000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialProov Competitors (3)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| OOVA | Venture Capital-Backed | New York, NY | 00 | 00.00 | 000000000 | 00.00 |
| 00000000000000 | Venture Capital-Backed | Dublin, Ireland | 000 | 00000 | 00000000000 | 00000 |
| 000000 000000 | Private Equity-Backed | Austin, TX | 000 | 00000 | 00 000000 | 00000 |
Proov Patents
Proov Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210055310-A1 | Method and apparatus for a pregnanediol urine assay | Pending | 19-Aug-2019 | 0000000000 | |
| US-11131665-B1 | Method for evaluating urine of a subject to estimate the fertile window | Active | 22-Aug-2018 | 00000000000 | 00 |
| US-20210293800-A1 | Method for evaluating urine of a subject to estimate the fertile window | Granted | 22-Aug-2018 | 00000000000 | |
| EP-3731751-A4 | Systems and methods for tracking progesterone | Pending | 28-Dec-2017 | 00000000000 | 0 |
| EP-3731751-A1 | Systems and methods for tracking progesterone | Pending | 28-Dec-2017 | A61B5/14507 |
Proov Executive Team (5)
Proov Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Amy Beckley Ph.D | Proov | Co-Founder, Owner, Chief Executive Officer & Board Member | 000 0000 |
| Ellen Schell | Proov | Co-Founder, Chief Marketing Officer & Board Member | 000 0000 |
Proov Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialProov Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| GingerBread Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Hambrecht Ducera Growth Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Lightship Capital | Investment Bank | Minority | 000 0000 | 000000 0 | |
| Portfolia | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Service Provider Capital | Venture Capital | Minority | 000 0000 | 000000 0 |